HIV/AIDS Clinical Trial Network builds Black Clevelanders' trust in COVID-19 studies


The HIV/AIDS clinical trial network’s 30 sites have spent years building trust among historical marginalized communities so that more clinical trial participants come from communities of color. Educational outreach, awareness-raising efforts, and one-on-one conversations are among the strategies used to make the scientific process more transparent. The engagement model is upfront about abuses from the past and uses straightforward explanations with no medical jargon. Infectious disease experts are using the trust-building model to increase the racial diversity of participants in COVID-19 vaccine trials.

Related Stories